Boston Scientific (BSX)

SG&A Expenses

$7.16B

TTM · Period ending: · USD

BSX logo

BSX SG&A Expenses

Latest reported$7.16B
BSX TTM SG&A Expenses ($0.00 → $7.16B)
High-resolution chart · PNG

BSX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
7,159,000,000
7,072,000,000
6,888,000,000
6,666,000,000
6,487,000,000
6,217,000,000
5,984,000,000
5,751,000,000
5,431,000,000
5,339,000,000
5,190,000,000
4,974,000,000
4,850,000,000
4,661,000,000
4,506,000,000
4,496,000,000
4,444,000,000
4,400,000,000
4,359,000,000
4,233,000,000
4,151,000,000
3,828,000,000
3,787,000,000
3,852,000,000
3,880,000,000
4,050,000,000
3,941,000,000
3,795,000,000
3,651,000,000
3,574,000,000
3,557,000,000
3,493,000,000
3,422,000,000
3,343,000,000
3,282,000,000
3,228,000,000
3,199,000,000
3,166,000,000
3,091,000,000
3,040,000,000
3,001,000,000
2,922,000,000
2,874,000,000
2,850,000,000
2,862,000,000
2,905,000,000
2,903,000,000
2,874,000,000
2,791,000,000
2,709,000,000
2,674,000,000
2,589,000,000
2,549,000,000
2,585,000,000
2,661,000,000
2,675,000,000
2,722,000,000
2,719,000,000
2,659,000,000
2,727,000,000
2,735,000,000
2,732,000,000
2,764,000,000
4,232,000,000
4,275,000,000
4,308,000,000
4,613,000,000
3,147,000,000
3,426,000,000
3,357,000,000
3,034,000,000
3,015,000,000
2,739,000,000
2,887,000,000
3,013,000,000
3,067,000,000
3,067,000,000
2,992,000,000
2,730,000,000
2,440,000,000
2,165,000,000
1,908,000,000
1,814,000,000
1,861,000,000
1,921,000,000
1,825,000,000
1,742,000,000
1,540,000,000
1,331,000,000
1,248,000,000
1,171,000,000
1,124,000,000
1,078,000,000
1,032,000,000
1,002,000,000
1,010,000,000
993,000,000
977,000,000
961,000,000
910,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.